Lymphoma Canada is presenting a FREE WEBINAR on Tues Mar 26th.
Some types of lymphoma and CLL grow slowly and may not need treatment right away. If this is the case for you,… Continue reading
In line with the IWMF updates, we have added the updated publications to reflect the research results and discoveries over the last few years. Much of this information was presented at the 10th International Workshop on WM in October 2018.… Continue reading
Steven P. Treon, MD, PhD, reviews diagnostic criteria and discusses the role of molecular testing in helping clinicians diagnose and manage Waldenström macroglobulinemia.
Caregivers are often putting faced with putting the needs of others above their own. It is being more widely acknowledged how damaging this can be on both the caregiver and the patients. Emotionally and physically.
The Leukemia… Continue reading
From the Cure Talks Cancer, this podcast features interviews with patients, survivors, caregivers, advocates and health care professionals
To read more, visit https://www.curetoday.com/articles/cure-honors-nine-who-help-people-with-rare-blood-cancers
Source: https://audioboom.com/posts/7146894-mpn-heroes-make-a-difference-in-the-rare-blood-cancer-space
Source: Lymphoma News Today
A Phase 1/2 trial is evaluating Loxo Oncology‘s BTK inhibitor LOXO-305 in leukemia and lymphoma patients who failed, or were intolerant to, approved BTK inhibitors.
The trial, so far being conducted… Continue reading
Cure Magazine has some great articles we think you will enjoy. They also have a newsletter.
Visit the Cure site at https://www.curetoday.com/articles
Join Dr. Stephen Ansell from Mayo Clinic, Dr. Jorge Castillo from Dana Farber and Carl Harrington from IWMF for this Cancercare webinar on
Wednesday, April 10
1:30pm Atlantic
FREE
Registration required
Listen in by phone or online
REGISTERHerbert Eradat, MD, MS, Director of Program in CLL & Waldenstrom’s Macroglobulinemia, UCLA Lymphoma & BMT/CAR-T Cell Program, Associate Professor of Medicine, David Geffen School of Medicine presented the following at the 2018 Lymphoma Research Foundation (LRF) Annual North American… Continue reading
